← Open Payments lookup

OMOLOLA FAGBOYEGUN: Open Payments

NPI 1982322814 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,551 in 54 payments from 9 companies in 2025. Trend: 2023 $1,726 · 2024 $1,795 · 2025 $2,551

Food & beverage: $2,441Education: $109
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.27$896
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$388
Janssen Pharmaceuticals, Inc5$311
Janssen Scientific Affairs, LLC2$286
Neurocrine BioSciences, Inc.4$218
Luye Pharma (USA) Ltd.5$207
Otsuka America Pharmaceutical, Inc.4$173
Alkermes, Inc.2$56
ABBVIE INC.1$16

Products named: INVEGA SUSTENNA, AUSTEDO XR, CAPLYTA, UZEDY, INGREZZA, ERZOFRI EXTENDED-RELEASE, ABILIFY MAINTENA, ARISTADA.

Industry payments across TX — which companies pay providers there.